Sacubitril and valsartan protect from experimental myocardial infarction by ameliorating oxidative damage in Wistar rats

Background: Sacubitril (SAC), a neprilysin inhibitor prevent degradation of neprilysin and activate cGMP signaling pathways leading to rise in blood volume concurrent to blood pressure by means of vasoactive peptides, adrenomedullin, and bradykinin. Objective: The aim of this study was to evaluate t...

Full description

Bibliographic Details
Main Authors: Mohd Imran, Md Quamrul Hassan, Md Sayeed Akhtar, Obaid Rahman, M. Akhtar, Abul Kalam Najmi
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Clinical and Experimental Hypertension
Subjects:
Online Access:http://dx.doi.org/10.1080/10641963.2018.1441862